| scholarly article | Q13442814 |
| P50 | author | Philip W. Kantoff | Q42532150 |
| Shehzad Basaria | Q44358165 | ||
| Thiago Gagliano-Jucá | Q47445348 | ||
| Thomas Travison | Q87644876 | ||
| Karol M Pencina | Q91565844 | ||
| Adam S Kibel | Q101212255 | ||
| P2093 | author name string | Elizabeta Nemeth | |
| Tomas Ganz | |||
| Mary-Ellen Taplin | |||
| Paul L Nguyen | |||
| Robert R Edwards | |||
| Grace Huang | |||
| Zhuoying Li | |||
| P2860 | cites work | Hepcidin, a urinary antimicrobial peptide synthesized in the liver | Q24290609 |
| The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
| The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? | Q24685741 | ||
| Hepcidin and iron regulation, 10 years later | Q27690828 | ||
| Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation | Q28186993 | ||
| Identification of erythroferrone as an erythroid regulator of iron metabolism | Q28240988 | ||
| Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy | Q28258997 | ||
| Association of anemia with worsened activities of daily living and health-related quality of life scores derived from the Minimum Data Set in long-term care residents | Q30574079 | ||
| Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. | Q33312408 | ||
| Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point | Q33615967 | ||
| Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis | Q33640979 | ||
| Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. | Q33767866 | ||
| Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone | Q34130847 | ||
| Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate | Q34215208 | ||
| Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review | Q34286438 | ||
| Anemia of chronic disease. | Q34401570 | ||
| Development of selective androgen receptor modulators (SARMs). | Q34558010 | ||
| Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer | Q35022837 | ||
| Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts | Q35137175 | ||
| Serum ferritin and the iron status of Canadians | Q35959849 | ||
| Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells | Q36698689 | ||
| Low testosterone levels and the risk of anemia in older men and women | Q37104301 | ||
| Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis | Q37113079 | ||
| Association between sex steroid hormones and hematocrit in a nationally representative sample of men | Q37173909 | ||
| Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth | Q37196025 | ||
| The regulation of hepcidin and its effects on systemic and cellular iron metabolism. | Q37346708 | ||
| Androgens and erythropoiesis: past and present | Q37507425 | ||
| Anemia of inflammation | Q38234242 | ||
| Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial | Q38380236 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Global Burden of Urologic Cancers, 1990-2013. | Q39060012 | ||
| Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia | Q39093537 | ||
| Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures | Q39320017 | ||
| Androgen therapy of aplastic anaemia | Q39780093 | ||
| Androgens and Erythropoiesis | Q39927273 | ||
| Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer | Q40097939 | ||
| Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy | Q42060244 | ||
| Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro | Q42675717 | ||
| Anemia in the elderly: clinical implications and new therapeutic concepts | Q42716196 | ||
| Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis | Q43181603 | ||
| Relationship between haemoglobin and serum testosterone in normal children and adolescents and in boys with delayed puberty | Q43779993 | ||
| Long-term effects of androgen deprivation therapy in prostate cancer patients | Q44033179 | ||
| Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial | Q44070350 | ||
| Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer | Q44765115 | ||
| Immunoassay for human serum erythroferrone | Q46046862 | ||
| Serum testosterone levels correlate with haemoglobin in middle-aged and older men. | Q46120526 | ||
| Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy | Q46875718 | ||
| Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer | Q46908336 | ||
| Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial. | Q47427787 | ||
| Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer | Q47760342 | ||
| The cause of the sexual differences in erythrocyte hemoglobin and serum iron levels in human adults | Q47972383 | ||
| Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke | Q48446294 | ||
| Radiotherapy and short-term androgen deprivation for localized prostate cancer. | Q51021354 | ||
| Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. | Q51244776 | ||
| Cardiovascular disease associated with androgen-deprivation therapy: time to give it due respect. | Q53584843 | ||
| Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer. | Q55278779 | ||
| Immunoassay for human serum hepcidin | Q56489921 | ||
| Anemia After Orchiectomy | Q58050938 | ||
| Mechanism of Testosterone Action in Erythropoiesis | Q59091935 | ||
| Endothelial function does not relate to haemoglobin or serum erythropoietin concentrations and these do not explain the gender difference in endothelial function in healthy middle-aged men and women. | Q64934889 | ||
| Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men | Q67682505 | ||
| Effect of androgens on maturation and metabolism of erythroid tissue | Q67833342 | ||
| Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy | Q71697230 | ||
| Variation of the hemoglobin level with age and sex | Q73645606 | ||
| Bilateral orchiectomy with or without flutamide for metastatic prostate cancer | Q77374114 | ||
| Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer | Q80285083 | ||
| Association of anemia with clinical outcomes in stable coronary artery disease | Q80724153 | ||
| Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population | Q85825298 | ||
| Erythropoietin | Q87764334 | ||
| Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2 | Q90387360 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E1185-E1193 | |
| P577 | publication date | 2018-10-16 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer | |
| P478 | volume | 315 |
Search more.